CLP1 was the first mammalian RNA kinase to be identified. However, determining its in vivo function has been elusive. Here we generated kinase-dead Clp1 (Clp1 K/K ) mice that show a progressive loss of spinal motor neurons associated with axonal degeneration in the peripheral nerves and denervation of neuromuscular junctions, resulting in impaired motor function, muscle weakness, paralysis and fatal respiratory failure. Transgenic rescue experiments show that CLP1 functions in motor neurons. Mechanistically, loss of CLP1 activity results in accumulation of a novel set of small RNA fragments, derived from aberrant processing of tyrosine pre-transfer RNA. These tRNA fragments sensitize cells to oxidative-stress-induced p53 (also known as TRP53) activation and p53-dependent cell death. Genetic inactivation of p53 rescues Clp1 K/K mice from the motor neuron loss, muscle denervation and respiratory failure. Our experiments uncover a mechanistic link between tRNA processing, formation of a new RNA species and progressive loss of lower motor neurons regulated by p53.
CLP1 was the first mammalian RNA kinase to be identified. However, determining its in vivo function has been elusive.
Here we generated kinase-dead Clp1 (Clp1 K/K ) mice that show a progressive loss of spinal motor neurons associated with axonal degeneration in the peripheral nerves and denervation of neuromuscular junctions, resulting in impaired motor function, muscle weakness, paralysis and fatal respiratory failure. Transgenic rescue experiments show that CLP1 functions in motor neurons. Mechanistically, loss of CLP1 activity results in accumulation of a novel set of small RNA fragments, derived from aberrant processing of tyrosine pre-transfer RNA. These tRNA fragments sensitize cells to oxidative-stress-induced p53 (also known as TRP53) activation and p53-dependent cell death. Genetic inactivation of p53 rescues Clp1 K/K mice from the motor neuron loss, muscle denervation and respiratory failure. Our experiments uncover a mechanistic link between tRNA processing, formation of a new RNA species and progressive loss of lower motor neurons regulated by p53.
RNA molecules undergo co-and post-transcriptional processing, leading to mature, functional RNAs. In mammals and archaea CLP1 proteins are kinases that phosphorylate the 59 hydroxyl ends of RNA [1] [2] [3] . Human CLP1 is a component of the messenger RNA 39-end cleavage and polyadenylation machinery 4, 5 , and studies in yeast have postulated a function for CLP1 in coupling mRNA 39-end processing with RNA polymerase II (Pol II) transcriptional termination [6] [7] [8] . Unique to mammals is the association of CLP1 with the tRNA splicing endonuclease (TSEN) complex 9 . TSEN proteins remove the intron present within the anticodon loop of numerous pre-transfer RNAs (pre-tRNAs), generating 59 and 39 tRNA exon halves 10 . Within the TSEN complex, CLP1 phosphorylates 39 tRNA exons in vitro 1 , potentially contributing to tRNA splicing in mammals 11 . Although CLP1 may participate in multiple RNA pathways and was the first mammalian kinase identified that phosphorylates RNA, the in vivo function of CLP1 in mammalian cells has remained elusive.
We report the generation and phenotypic analysis of CLP1 kinasedead mice. These mice develop a progressive loss of lower motor neurons, resulting in fatal deterioration of motor function. We also show that inactivation of CLP1 kinase activity results in the accumulation of previously unreported tyrosine tRNA fragments that sensitize cells to activation of p53 in response to oxidative stress.
Neonatal lethality of Clp1 K/K mice
To assess the in vivo function of CLP1, first we generated global Clp1-knockout mice. We never obtained any viable Clp1-null offspring, even when analysed at embryonic day (E)6.5, indicating very early embryonic lethality. Consequently, we generated mice carrying a single amino-acid change, lysine to alanine at position 127 (K127A), which is located within the Walker A ATP-binding motif (Supplementary Fig. 1a, b ). This mutation abolishes CLP1 kinase activity 1 . Mice heterozygous for the K127A substitution (Clp1
) were intercrossed to generate homozygous offspring (Clp1
). Western blotting showed that the CLP1 K127A mutant protein was expressed at normal levels, and that the Clp1 K/K mutation impaired 59 phosphorylation of a small duplex RNA substrate ( Supplementary Fig. 1c, d ). Therefore, we successfully generated a knock-in mouse expressing kinasedead CLP1.
Clp1 K/K mice were born at a normal Mendelian ratio. However, on a C57BL/6 background, all Clp1 K/K mice died within hours of birth, probably owing to respiratory failure (Fig. 1a, b) . This phenotype had complete penetrance (n . 50). Embryos and newborn Clp1 K/K mice had overtly normal lung development and morphogenesis, as indicated by caveolin 1, surfactant A and surfactant C expression ( Supplementary Fig. 2 ). However, all newborn Clp1 K/K mice and E18.5 embryos exhibited a lordotic body posture and dropping forelimbs, indicative of impaired motor functions (Fig. 1a and Supplementary Fig. 3a) . Newborn Clp1 K/K mice also showed reduced birth weight and were hyporesponsive to stimuli ( Supplementary  Fig. 3b) ; similar phenotypes in KIF1B-mutant mice have been ascribed to motorsensory neuronal defects 12 . We therefore analysed neuromuscular junctions (NMJs) in the diaphragm.
Control E18.5 embryos showed the characteristic innervation pattern of the phrenic motor nerve bundle and had normal NMJs, defined by colocalization of presynaptic terminals with postsynaptic clusters of acetylcholine receptors (AChRs) as well as the presence of S100
1 Schwann cells in the endplate (Fig. 1c and Supplementary Fig. 4 ). E18.5 Clp1 K/K embryos showed defasciculation of the main phrenic nerve bundle; primary branches were mislocalized to the periphery, and denervation of the ventral and dorsal diaphragm was prominent in all Clp1 K/K mutants (Fig. 1c) . NMJs were formed, but axon terminals appeared undifferentiated, with smaller AChR clusters (Fig. 1d) . S100 expression at the NMJ was absent in Clp1 K/K embryos, although the Schwann cells seemed to be functionally intact as surviving peripheral axons were myelinated ( Supplementary Fig. 4 ). The development and morphology of the heart, liver, kidney, colon, bladder, spleen and thymus appeared normal at E18.5. Thus, all newborn Clp1 K/K mice show impaired innervation of the diaphragm, which seems to cause lethal respiratory failure and neonatal death.
Embryonic loss of motor neurons
We next assessed NMJs in the diaphragm during embryogenesis. In Clp1 K/K embryos, denervation was not found at E14.5. However, we observed partial denervation and pronounced alteration in NMJ morphology at E16.5, followed by a severe defect in the innervation of the NMJs of the diaphragm at E18.5 (Fig. 1c, d and Supplementary  Figs 4-6) . Moreover, whereas Clp1 K/K embryos had normal numbers of choline acetyl transferase (ChAT)-expressing spinal motor neurons at E14.5 and E16.5, the numbers of ChAT 1 motor neurons markedly declined in the spinal cord of E18.5 Clp1 K/K embryos (Fig. 2a, b and Supplementary Fig. 7a, b) . The numbers of motor neurons also declined in wild-type embryos due to pruning, which has been linked to oxidative stress exposure 13 . NeuN staining to detect all neurons showed that the observed reduction in neuronal numbers was due to the loss of ChAT 1 motor neurons ( Supplementary Fig. 7c ). To confirm loss of motor neurons in the spinal cord, we crossed green fluorescent protein (GFP)-tagged Hb9 (also known as Mnx1) transgenic mice onto a Clp1 K/K background. Genetic GFP tagging showed that E14.5 Clp1 K/K embryos have similar numbers of Hb9 1 cells as age-matched control embryos, but the numbers of Hb9-GFP 1 cells declined in E18.5 Clp1 K/K embryos (Supplementary Fig. 7d ). In whole-mount visualizations of Hb9-GFP 1 E10.5 embryos, both development and segmental-motor-axon outgrowth were comparable between Clp1 K/K and control embryos; three-dimensional reconstructions further demonstrated comparable motor-axon outgrowth in the thoracic region (segment T6-T7) in E12.5 embryos K/K (n 5 14) mice. **P , 0.01, ***P , 0.001 (t-test).
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( Supplementary Fig. 8a, b) . Moreover, the overall morphology of motor terminal branches and the pathfinding of motor neurons at the intercostal muscles was comparable ( Supplementary Fig. 8c ). Thus, genetic inactivation of the RNA kinase function of CLP1 results in progressive loss of motor neurons in the cervical and lumbar spinal cord, with aberrant innervations and formation of NMJs in the diaphragm, and neonatal death.
Progressive loss of motor functions
The 100% lethality of Clp1 K/K pups at birth was observed on a C57BL/6 background. Similarly, we observed 100% lethality on a BALB/c background. However, when crossing the mutation onto a CBA/J mouse background, we obtained viable pups homozygous for the Clp1 K/K mutation ( Supplementary Fig. 9a ). These mice showed motor ataxia ( Supplementary Fig. 9b ), impaired muscle strength, an altered walking stride, and diminished balance as determined by the fixed and accelerated Rotarod tests ( Fig. 2c-g ), all indications of motor defects. The muscle weakness and impaired motor functions observed in these mice were progressive ( Fig. 2e-g ). Mice started to die around week 23 after birth, and older Clp1 K/K mice developed limb paralysis ( 14 , in the sciatic nerves of adult Clp1 K/K mice (Fig. 3e ). In line with motor-neuron loss, we observed a marked reduction in the number of large diameter (type 1A alpha) fibres, whereas the smaller sensory fibres were largely preserved ( Supplementary Fig. 12d ). Dorsal root ganglion (DRG) sensory neurons showed normal morphology and outgrowth. Whether developmental alterations in myelination also contribute to the phenotype needs to be further assessed. We also observed regional denervation and fragmentation of NMJs in the diaphragm, and in various limb and head skeletal muscles, resulting in skeletal muscle atrophy; slow-twitch muscles (soleus, gluteus) were less affected than the fast-twitch extensor digitorum longus or gastrocnemius muscles (Fig. 3f, g 
CLP1 promotes efficient tRNA exon generation
To assess potential roles in RNA metabolic processes, first we evaluated the function of CLP1 in mRNA 39-end cleavage 4 . The kinetics of a pre-mRNA cleavage reaction in nuclear extracts from wild-type and Clp1 K/K mouse embryonic fibroblasts (MEFs) were similar (Supplementary Fig. 16a ), suggesting that ATP binding and/or hydrolysis by CLP1 are dispensable for mRNA 39-end cleavage. CLP1 has been implicated in RNA interference (RNAi) by its ability to phosphorylate small interfering RNAs in vitro 1 . We therefore assessed whether cellular microRNA (miRNA) processing or stability were affected by the CLP1 K127A mutation. However, the levels of various preand mature miRNAs did not differ between wild-type and Clp1 K/K MEFs and tissues, and no effect on miRNA function was detected using a luciferase reporter assay ( Supplementary Fig. 16b, c) . Furthermore, we found no significant differences in pre-mRNA splicing ( Supplementary Fig. 17 ).
It has been reported that CLP1 is part of the human TSEN complex 9 and is able to phosphorylate tRNA 39 exons 1 . We therefore tested whether the Clp1 K/K mutation affects tRNA splicing. Notably, nuclear extracts from Clp1 K/K MEFs generated significantly lower levels of tRNA exons (Fig. 4a) . In addition, tRNA 39 exon halves formed by incubation with nuclear extracts isolated from Clp1 K/K MEFs lacked a 59 phosphate group; 59 phosphorylation and exon generation were rescued by ectopic expression of wild-type CLP1 in Clp1 K/K MEFs ( Supplementary Fig. 18a-e) . Similarly, pre-tRNA cleavage was partially restored in Clp1 K/K MEFs stably expressing wild-type CLP1, whereas overexpression of the CLP1 K127A mutant inhibited RNA phosphorylation ( Supplementary Fig. 19a-d) . Affinity-purified CLP1(K127A)-containing TSEN complexes were deficient in the generation of tRNA exons, most probably due to reduced levels of TSEN2, TSEN34 and TSEN54 subunits (Fig. 4b, c) ; mRNA levels of TSEN2, TSEN34 and TSEN54 were not affected in Clp1
K/K MEFs (data not shown). Thus, the RNA kinase activity of CLP1 is important ChAT + motor neurons 
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for the integrity of the TSEN complex and for efficient generation of tRNA exons (Supplementary Fig. 20 ).
Accumulation of novel tyrosine tRNA fragments
Whereas most tRNAs do not contain introns, all mouse tyrosine (Tyr)-tRNA genes contain an intronic sequence. Notably, in Clp1 K/K MEFs we detected accumulation of ,41-46-nucleotide Tyr-tRNA fragments using a northern probe against the 59 exon (Fig. 4d) . RNA sequencing revealed that this fragment comprises a 59 leader followed by 59 exon Tyr-tRNA sequences (Fig. 4e and Supplementary Fig. 21a, b) . Enzymatic treatments uncovered a 59 triphosphate modification (Supplementary Fig. 21c ), indicating that this novel tRNA fragment contains a full-length 59 leader sequence starting with the transcription initiator PPP-nucleotide. RNAi-mediated silencing of TSEN2 in MEFs resulted in decreased levels of tRNA fragments (Fig. 4f and Supplementary Fig. 21d ). Bioinformatic and northern blotting analyses revealed minor accumulation of such 59 fragments from other introncontaining tRNAs, mostly arginine tRNAs ( Supplementary Fig. 22) .
A similar accumulation of tyrosine tRNA fragments was observed in the spinal cord of C57BL/6 Clp1 K/K neonates and 4-month-old Clp1 K/K mice on a CBA/J background (Fig. 4d) . Moreover, we observed increased levels of these tRNA fragments in cortex, muscle, heart, kidney, muscle and liver (Supplementary Fig. 23a ). Steady-state levels of mature tRNAs seemed to be normal in MEFs, the spinal cord of C57BL/6 Clp1 K/K neonates and in postnatal CBA/J Clp1 K/K mice ( Supplementary Fig. 23b ). Thus, loss of CLP1 kinase activity results in the accumulation of novel RNA fragments derived from pre-tRNA.
Oxidative-stress-induced cell death
Other tRNA fragments, for example, tRNA-derived, stress-induced small RNAs (tiRNAs), are generated in the cytoplasm by the endonuclease angiogenin acting on mature tRNAs 16, 17 . Similar to tiRNAs, Tyr-tRNA fragments were also induced by H 2 O 2 , but were not generated by angiogenin. Rather, Tyr-tRNA fragments were present in the nucleus and were derived from pre-tRNAs actively transcribed by RNA Pol III ( Supplementary Fig. 24a-d) . Because Tyr-tRNA fragments were strongly induced by H 2 O 2 , we proposed that CLP1 might have a role in the oxidative stress response. In wild-type MEFs, the Tyr-tRNA fragments also accumulated after exposure to the reactive oxygen species (ROS) inducers glucose oxidase, menadione and paraquat dichloride, but not nefazodone ( Supplementary Fig.  25a-d) . Treatment with the mitochondrial 'poisons' carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) and rotenone, the apoptosis inducer staurosporine, the protein-synthesis inhibitor puromycin, and the DNA-damaging agent camptothecin did not trigger the accumulation of Tyr-tRNA fragments ( Supplementary Fig. 25e, f) . Importantly, on H 2 O 2 and glucose oxidase challenge, we observed increased death of Clp1 K/K MEFs; re-expression of wild-type CLP1 restored the survival rate to that of control MEFs (Fig. 5a and Supplementary Fig. 26a ).
Extending our studies to neurons, we trans-differentiated wildtype and Clp1 K/K MEFs into Hb9-GFP 1 motor neurons 18 , and observed typical sodium and potassium currents, as well as normal action potentials and responses to excitatory and inhibitory transmitters ( Fig. 5b and Supplementary Fig. 26b-f) . However, the resting membrane potential of Clp1 K/K motor neurons was depolarized by over 10 mV relative to control motor neurons (257.0 6 2.0 mV for n 5 11 Clp1 1/1 and 246.9 6 3.0 mV for n 5 10 Clp1 K/K motor neurons; t-test ,0.01), suggesting that Clp1 K/K motor neurons exhibit ion-exchange abnormalities. Cell input resistance was similar between the two groups of neurons (367 6 94 MV for n 5 11 Clp1 1/1 and 511 6 63 MV for n 5 10 Clp1 K/K motor neurons; t-test .0.2). Importantly, similar to MEFs, trans-differentiated Clp1 K/K motor neurons were more sensitive to H 2 O 2 -induced cell death than wild-type motor neurons (Fig. 5c) . Thus, loss of the catalytic activity of CLP1 results in enhanced motor-neuron death in response to oxidative stress.
Motor-neuron loss is mediated by p53
Oxidative stress has been linked to a p53-regulated cell death pathway through serine-18 phosphorylation, which has been shown to regulate p53-dependent transcription [19] [20] [21] . In response to H 2 O 2 , Clp1 K/K MEFs showed hyperphosphorylation of p53 at serine 18 and increased induction of the p53-target gene p21 (also known as CDKN1A); reexpression of wild-type CLP1 rescued the H 2 O 2 -induced serine-18 
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hyperphosphorylation ( Fig. 5d and Supplementary Fig. 27a, b) . Similarly, we found p53 serine-18 hyperphosphorylation in Clp1 K/K MEFs in response to the ROS-inducing agent glucose oxidase but not the DNA-damaging agent camptothecin ( Supplementary Fig. 27c, d ). Most importantly, genetic inactivation of p53 rescued Clp1 K/K MEFs from enhanced death after H 2 O 2 treatment (Fig. 5e) . Overexpression of two different tyrosine tRNA fragments in the mouse motor neuron cell line NSC-34 also resulted in enhanced p53 activation in response to H 2 O 2 ( Supplementary Fig. 28a, b) . Thus, kinase-dead CLP1 renders MEFs more susceptible to oxidative-stress-induced cell death through a p53-regulated pathway.
Notably, we observed a complete rescue of neonatal lethality in p53
Clp1
K/K mice on the 100% lethal C57BL/6 background (Fig. 5f ). The viable p53
2/2

Clp1
K/K pups showed normal extension of the lungs (Fig. 5g) , normal innervation of the diaphragm, and rescue of NMJ formation (Fig. 5h, i) . The numbers of ChAT-( Supplementary Fig. 29a, b) and SMI-32-labelled (data not shown) motor neurons in the spinal cord were comparable to that of newborn and 1-month-old control mice. Furthermore, 1-month-old p53 2/2
K/K mice did not show muscle weakness ( Supplementary Fig.  29c-e 
K/K mice could not be assessed because they developed tumours due to the loss of p53. To test whether oxidative stress is involved in the phenotype, we treated pregnant Clp1 K/1 females (crossed to Clp1 K/1 males on the lethal C57BL/6 background) with the ROS scavenger N-acetylcysteine (NAC). NAC treatment resulted in viable Clp1 K/K pups and partially restored innervation of the diaphragm (Supplementary Fig. 30 ). However, pups from NAC-treated mothers died within a week after birth, probably because in vivo ROS scavenging by NAC is incomplete and/or other pathways contribute to the phenotype. Thus, ROS and p53 constitute critical in vivo pathways that mediate motor neuronal loss and neonatal death of Clp1 K/Kmutant mice.
Transgenic rescue of motor-neuron defects
To provide definitive proof that the CLP1 kinase-dead mutation acts in motor neurons, we introduced a Flag-tagged wild-type CLP1-IRESeGFP transgene under the control of the motor-neuron promoter Hb9 (ref. 22 ) into control and Clp1 K/K mice on a C57BL/6 background ( Fig. 6a and Supplementary Fig. 31a, b) . Transgenic expression of wild-type CLP1 completely rescued neonatal lethality of Clp1 K/K mice and restored normal numbers of ChAT 1 motor neurons in the spinal cord of newborns (Fig. 6b, c and Supplementary Fig. 31c ). Moreover, Hb9-CLP1 transgenic Clp1 K/K mice did not accumulate Tyr-tRNA fragments in the spinal cord (Fig. 6d) , providing direct evidence that accumulation of these tRNA fragments is dependent on the loss of CLP1 activity. Phrenic nerve defasciculation and mislocalization, and the defects in NMJ formation and innervation of the diaphragm in Clp1 K/K mice were also rescued by transgenic expression of wild-type CLP1 in Clp1 K/K mice; similar results were obtained for intercostal muscles (Fig. 6e and Supplementary Fig. 32a-c) . Moreover, S100 1 Schwann cells were restored (Fig. 6f) , indicating that the observed absence of terminal Schwann cells is probably due to the impaired function of CLP1 in motor neurons.
Specific rescue of CLP1 expression in motor neurons but not other cell types led us to test whether kinase-dead CLP1 might affect general metabolism, which could then contribute to the observed phenotype. Using calorimetric experiments, Clp1 K/K mice did not exhibit any apparent alterations in food and water intake, O 2 consumption, CO 2 production, respiratory exchange rate or heat generation as compared to the Clp1 1/1 transgenic littermates; moreover, heat generation upon cold exposure and recovery of body temperature, as a measure for sympathetic nerve activity 23 , were comparable ( Supplementary Fig.  33a-h ). These transgenic rescue experiments provide direct evidence that CLP1 acts in lower motor neurons and that mutant-CLP1-mediated motor defects are responsible for the neonatal lethality phenotype.
Conclusions
Our results provide the first report on the in vivo function of the RNA kinase CLP1. CLP1 kinase-dead mice develop progressive loss of spinal motor neurons, leading to muscle denervation and paralysis. Inactivation of CLP1 kinase activity results at the same time in poor generation of tRNA exon halves and accumulation of novel, hitherto undescribed 59 leader exon tRNA fragments. This paradoxical 
Viability ( RESEARCH ARTICLE observation could be explained by a defect in tRNA exon ligation in a CLP1 kinase-dead background regulated by oxidative stress. Different tRNA fragments have been previously reported in a variety of organisms 24, 25 . For example, the cytoplasmatic pre-tRNA-derived tRF-1001 fragment, a 39 trailer molecule, seems to have a role in cell viability 26 . Stress-induced tiRNAs, derived from the processing of mature tRNAs in the cytoplasm 16 , inhibit initiation of protein translation by displacing the eIF4F complex from mRNAs 17 . We did not observe translation inhibition by our novel Tyr-tRNA fragments in metabolic labelling experiments; rather, we found that such fragments sensitize cells to oxidative-stress-induced activation of the p53 tumour suppressor pathway. The exact molecular mechanism(s) by which these tRNA fragments couple to the p53 pathway need to be determined. Importantly, motor-neuron loss was rescued in vivo either by reducing oxidative stress or by genetically inactivating p53.
Our experiments uncover an unexpected mechanistic link between tRNA processing, formation of a new RNA species, and a p53-regulated progressive loss of lower motor neurons. These results provide a conceptual and experimental framework for how alterations in tRNA metabolism can affect spinal motor neurons, and might help explain fundamental molecular principles in diseases such as amyotrophic lateral sclerosis or spinal muscular atrophy.
METHODS SUMMARY
Generation of kinase-dead Clp1 K/K and Hb9-CLP1 transgenic mice. Complete mutant and knock-in Clp1 K/K mice were generated by homologous recombination. The Clp1 K/K allele was backcrossed five times to C57BL/6 or CBA/J mice. p53-deficient mice and Hb9-GFP transgenic mice were obtained from The Jackson Laboratory. Hb9-CLP1 transgenic mice containing the Hb9 promoter driving Flag-tagged mouse CLP1 and eGFP were generated in house. All mice were maintained according to institutional guidelines. Phenotyping. Behavioural phenotyping and assessment of motor functions were performed as described in Supplementary Information. Diaphragm and intercostals muscles were stained as described previously 27 . Anti-neurofilament and anti-synaptophysin antibodies were used to label axons and presynaptic nerve terminals, respectively. Antibodies to S100 were used to visualize Schwann cells. Postsynaptic AChRs were detected with Alexa-594-conjugated a-bungarotoxin. Spinal motor neurons were stained with anti-ChAT and anti-SMI-32 antibodies. MEFs and trans-differentiated motor neurons were generated as described 18 . Pre-tRNA splicing. Pre-tRNA substrates were generated by in vitro transcription. Labelled yeast pre-tRNA
Phe or human pre-tRNA Tyr were incubated with cell extracts or TEV eluates, and formation of mature tRNA and/or tRNA exons was monitored by phosphorimaging. Northern blot analysis. For tRNA detection, total RNA from tissues and cultured cells was isolated, subjected to gel electrophoresis and blotted on Hybond-N 1 membranes. Blots were hybridized using [59 32 P]-labelled DNA/LNA probes to detect Tyr-tRNA 59 and 39 exons. Identification of Tyr-tRNA fragments. Total RNA from primary MEFs was separated by gel electrophoresis. The region containing RNA of 37-50 nucleotides in size was excised and sequenced using an Illumina platform. Reads were aligned to the mouse genome (http://gtrnadb.ucsc.edu/Mmusc/Mmusc-bylocus-txt.html) using bedtools (v. 2.16.2). 
Clp1
1/1 transgenic, Clp1 K/K and Clp1 K/K transgenic mice. Northern blot analyses of total RNA using a probe complementary to the 59 exon of Tyr-tRNA. U6 RNA served as a loading control. e, Whole-mount immunostaining depicting NMJs in diaphragms of 3-day-old Clp1 1/1 transgenic and Clp1 K/K transgenic littermates. Postsynaptic AChR clusters (red; a-bungarotoxin) and innervating motor axons and presynaptic nerve terminals (green; neurofilament/synaptophysin immunostaining) are shown. f, Whole-mount immunostaining of the diaphragms of 3-day-old Clp1 1/1 transgenic, Clp1 K/K and Clp1 K/K transgenic littermates showing postsynaptic AChR clusters (red; a-bungarotoxin) and S100
1 Schwann cells (green). Scale bars: a, c, e, 50 mm; f, 100 mm.
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